Today, Myriad Genetics, Inc (NASDAQ: MYGN) Takes Center Stage

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

The company is listed on the NASDAQ and operates within the Diagnostics & Research industry segment. The current market capitalization of Myriad Genetics, Inc is $1.30B. A total of 1.18 million shares were traded on the day, compared to an average of 952.00K shares.

In the most recent transaction, DIAZ PAUL J sold 15,000 shares of MYGN for 22.93 per share on Oct 11 ’24. After the transaction, the President and CEO now owns 962,378 company shares. In a previous transaction on Oct 11 ’24, DIAZ PAUL J bought 15,000 shares at 22.93 per share.

Among the insiders who bought shares, Ancona Margaret acquired of 11,538 shares on Aug 21 ’24 at a per-share price of $27.82. In another insider transaction, DIAZ PAUL J sold 15,000 shares at $26.72 per share on Sep 11 ’24. Company shares held by the President and CEO now total 977,378.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, MYGN has a high of $29.30 and a low of $12.87.

As of this writing, MYGN has an earnings estimate of $0.03 per share for the current quarter. EPS was calculated based on a consensus of 15.0 estimates, with a high estimate of $0.04 per share and a lower estimate of $0.02.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. MYGN’s latest balance sheet shows that the firm has $338.80M in Cash & Short Term Investments as of fiscal 2021. There were $92.30M in debt and $204.30M in liabilities at the time. Its Book Value Per Share was $8.04, while its Total Shareholder’s Equity was $967.80M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MYGN is Buy with a score of 3.47.

Most Popular

Related Posts